2232. Nasal Microbiota Changes are Associated with Progression to LRI following Respiratory Syncytial Virus URI in Hematopoietic Cell Transplant Recipients
Session: Poster Abstract Session: Microbiome: Non-GI
Saturday, October 29, 2016
Room: Poster Hall

Background: Respiratory syncytial virus (RSV) is one of the most common viral pathogens in hematopoietic cell transplant (HCT) recipients. It mainly causes upper respiratory infections (URI), but can progress in 1/3 of pts to lower respiratory tract infections (LRI) with high subsequent mortality. Bacterial co-infections have been associated with viral LRI; however the serial changes in nasal microbiota and correlation with development of RSV-LRI in HCT recipients have not been investigated. We aimed to understand the serial changes, including decrease in bacterial diversity and domination by particular bacterial groups, in nasal microbiome and its association with development of RSV-LRI in HCT recipients.

Methods: For a clinical trial in adult HCT recipients with RSV-URI, using a standardized collection method, we obtained weekly nasal wash samples from each pt up to day 30 from RSV diagnosis. These samples were analyzed by 16S ribosomal RNA gene sequencing and differences within and between pts were compared by assessing α-diversity (Shannon’s index) and β-diversity (UniFrac method). Generalized linear regression modeling was utilized to compare the serial changes in bacterial relative abundance between those who progressed to RSV-LRI versus those who did not.

Results: Of the 43 pts, the majority were White (25[58%]), females (22 [52%]), and underwent allogeneic HCT (30[70%]) for acute leukemia (17 [40%]). From analysis of 189 nasal wash samples (rarefaction: 1007 reads per sample), a significant loss of microbial diversity as early as one week was observed in pts who progressed to LRI versus those who did not. Principal Component Analysis (Figure) also revealed 2 distinct clusters between pts who progressed to LRI (Proteobacteria: e.g. Parasuterella) vs. those who recovered (Firmicutes: e.g. Staphylococcus) (Figure, P = 0.001).

Conclusion: A loss of diversity accompanied by increase of non-commensal bacterial groups was observed in pts with RSV who progressed to LRI. Perturbations in the nasal microbiome following viral infections during post-transplant period may be the harbinger of loss of the lung homeostatic immune defenses, leading to pneumonia, Learning more about the dynamic changes of nasal microbiome following RSV URI can add to risk stratification for pts who will progress to pneumonia.

Figure: Beta Diversity Ordination

Dimpy Shah, MD, MSPH, PhD1, Nadim J. Ajami, PhD2, Shashank S. Ghantoji, MD, MPH1, Samuel Shelburne, MD, PhD, FIDSA1, Danielle El-Haddad, MD1, Pankil Shah, MD, MSPH3, Pedro Piedra, MD4, Elizabeth Shpall, MD5, Dimitrios P. Kontoyiannis, MD, ScD, FIDSA6 and Roy F. Chemaly, MD, MPH, FIDSA, FACP7, (1)Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX, (2)Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, (3)The University of Texas MD Anderson Cancer Center, Houston, TX, (4)Baylor College of Medicine, Houston, TX, (5)Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, (6)Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, (7)Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX


D. Shah, None

N. J. Ajami, None

S. S. Ghantoji, None

S. Shelburne, None

D. El-Haddad, None

P. Shah, None

P. Piedra, None

E. Shpall, None

D. P. Kontoyiannis, •: Advisory Board , Research support
Pfizer: Research grant , Research support
Gilead: Invited lecturer , Speaker honorarium
Astellas: Consultant , Research support and Speaker honorarium
F2G: Consultant , Consulting fee
T2 Biosystems: Invited lecturer , Speaker honorarium
Mylan Inc: Invited lecturer , Speaker honorarium

R. F. Chemaly, None

See more of: Microbiome: Non-GI
See more of: Poster Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.